Systematic review: Tranexamic acid for upper gastrointestinal bleeding

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 9, 2008, Pages 752-758

  Gluud, L L ^a,b   Klingenberg, S L ^a   Langholz, S E ^b  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; TRANEXAMIC ACID;

BRAIN INFARCTION; CLINICAL TRIAL; COCHRANE LIBRARY; DEEP VEIN THROMBOSIS; EMBASE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW; SCISEARCH; SYSTEMATIC REVIEW; THROMBOEMBOLISM; UPPER GASTROINTESTINAL BLEEDING;

ANTIFIBRINOLYTIC AGENTS; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID; UPPER GASTROINTESTINAL TRACT;

EID: 41749118943     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03638.x     Document Type: Review

References (37)

1. Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995 311 : 222 6.
2. Blatchford O, Davidson LA, Murray WR, et al. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997 315 : 510 4.
3. Chassaignon C, Letoumelin P, Pateron D, et al. Upper gastrointestinal haemorrhage in Emergency Departments in France: causes and management. Eur J Emerg Med 2003 10 : 290 5.
4. Hernandez DS, Rodriguez LA. Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies. J Clin Epidemiol 2002 55 : 157 63.
5. Yavorski RT, Wong RK, Maydonovitch C, et al. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995 90 : 568 73.
6. Paspatis GA, Matrella E, Kapsoritakis A, et al. An epidemiological study of acute upper gastrointestinal bleeding in Crete, Greece. Eur J Gastroenterol Hepatol 2000 12 : 1215 20.
7. Ng W, Wong WM, Chen WH, et al. Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease. World J Gastroenterol 2006 12 : 2923 7.
8. Barkun A, Bardou M, Marshall JK, et al. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003 139 : 843 57.
9. Schemmer P, Decker F, Dei AG, et al. The vital threat of an upper gastrointestinal bleeding: risk factor analysis of 121 consecutive patients. World J Gastroenterol 2006 12 : 3597 601.
10. Lim CH, Vani D, Shah SG, et al. The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a prospective cohort study. Endoscopy 2006 38 : 581 5.
11. Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992 102 : 139 48.
12. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003 1 : CD002147.
13. Adamsen S, Bendix J, Kallehave F, et al. Clinical practice and evidence in endoscopic treatment of bleeding peptic gastroduodenal ulcer. Scand J Gastroenterol 2007 42 : 318 23.
14. Henry DA, O'Connell DL. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ 1989 298 : 1142 6.
15. Barer D, Ogilvie A, Henry D, et al. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med 1983 308 : 1571 5.
16. Hawkey GM, Cole AT, McIntyre AS, et al. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut 2001 49 : 372 9.
17. Gluud LL, Klingenberg SL, Langholz E. Tranexamic acid for upper gastrointestinal bleeding (protocol). Cochrane Database Syst Rev 2007 3 : CD006640.
18. Gluud LL. Bias in clinical intervention research. Am J Epidemiol 2006 163 : 493 501.
19. Cormack F, Chakrabarti RR, Jouhar AJ, et al. Tranexamic acid in upper gastrointestinal haemorrhage. Lancet 1973 1 : 1207 8.
20. Biggs JC, Hugh TB, Dodds AJ. Tranexamic acid and upper gastrointestinal haemorrhage - a double-blind trial. Gut 1976 17 : 729 34.
21. Engqvist A, Brostrom O, von Feilitzen F, et al. Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study. Scand J Gastroenterol 1979 14 : 839 44.
22. Bergqvist D, Dahlgren S, Hessman Y. Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Up J Med Sci 1980 85 : 173 8.
23. von Holstein CC, Eriksson SB, Kallen R. Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ 1987 294 : 7 10.
24. von Holstein CC, Eriksson SB, Kallen R. Tranexamic acid in gastric and duodenal bleeding. Scand J Gastroenterol Suppl 1987 137 : 71 4.
25. Collen D, Tytgat G, Claeys H, et al. Metabolism of plasminogen in healthy subjects: effect of tranexamic acid. J Clin Invest 1972 51 : 1310 8.
26. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006 354 : 353 65.
27. Sabovic M, Lavre J, Vujkovac B. Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transpl 2003 18 : 1388 91.
28. Rydin E, Lundberg PO. Tranexamic acid and intracranial thrombosis. Lancet 1976 2 : 49.
29. Endo Y, Nishimura S, Miura A. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura. JAMA 1988 259 : 3561 2.
30. Agnelli G, Gresele P, De Cunto M, et al. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report. Br J Obstet Gynaecol 1982 89 : 681 2.
31. Woo KS, Tse LK, Woo JL, et al. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. Br J Clin Pract 1989 43 : 465 6.
32. Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol 2002 68 : 307 9.
33. Mori T, Aisa Y, Shimizu T, et al. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007 82 : 838 9.
34. Molenaar IQ, Warnaar N, Groen H, et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transpl 2007 7 : 185 94.
35. Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir 1990 102 : 1 10.
36. Vermeulen M, Lindsay KW, Murray GD, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 1984 311 : 432 7.
37. Wijdicks EF, Hasan D, Lindsay KW, et al. Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage. Stroke 1989 20 : 1674 9.